Skip to main content
. 2020 Mar;12(3):803–812. doi: 10.21037/jtd.2019.12.72

Table 2. Procedural details.

Operative details Mean ± SD or frequencies (%)
Bypass time (min) 101.8±35.5
Ischemic time (min) 60.4±33.6
No. of distal anastomosis 2.9±0.8
   1 1/36 (2.8)
   2 4/36 (11.1)
   3 25/36 (69.4)
   4 6/36 (16.7)
Left internal mammary artery use 35/36 (97.2)
Arterial graft use 0.9±0.2
Vein graft use 1.9±0.7
Complete revascularization 31/36 (86.1)
Post op inotrope usage (any inotrope) 34/36 (94.4)
   Low dose (<10 mL/h) 31/34 (91.2)
   Moderate to high dose (>10 mL/h) 3/34 (8.8)
IABP use (before/after CABG) 6/36 (16.7)
Severe diffused disease (n=31) 14/31 (45.2)
No. of native target vessels <1.5 mm 49/91 (53.8)